Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
home | Welcome, sign in or click here to subscribe. | login |
print email to a friend reprints add to mydjc |
December 2, 2021
Seattle-based Audere, a digital nonprofit developing software to improve global health, will participate in a study with Fred Hutchinson Cancer Research Center, Jhpiego, Jomo Kenyatta University of Agriculture and Technology, MYDAWA, and University of Washington to develop and evaluate an ePharmacy platform for HIV pre-exposure prophylaxis delivery in Kenya. The study is funded by grants from the Bill & Melinda Gates Foundation. It involves partners across the global health space that will jointly design and execute a new end-to-end virtual care delivery model for HIV. The UW, in partnership with Fred Hutchinson Cancer Research Center and Jomo Kenyatta University of Agriculture and Technology, will lead the study's research design, data collection, analysis and dissemination. MYDAWA will create the virtual self-care model to provide individuals with online access to HIV testing, while connecting them with remote clinicians to initiate PrEP therapies. Jhpiego will provide technical assistance for PrEP services implementation and policy advocacy support.